title: Lung cancer in HIV Infection.
abstract: Lung cancer is the most prevalent non-AIDS-defining malignancy in the highly active antiretroviral therapy era. Smoking plays a significant role in the development of HIV-associated lung cancer, but the cancer risk is two to four times greater in HIV-infected persons than in the general population, even after adjusting for smoking intensity and duration. Lung cancer is typically diagnosed a decade or more earlier among HIV-infected persons (mean age, 46 years) compared to those without HIV infection. Adenocarcinoma is the most common histological subtype, and the majority of patients are diagnosed with locally advanced or metastatic carcinoma. Because pulmonary infections are common among HIV-infected individuals, clinicians may not suspect lung cancer in this younger patient population. Surgery with curative intent remains the treatment of choice for early-stage disease. Although there is increasing experience in using radiation and chemotherapy for HIV-infected patients who do not have surgical options, there is a need for prospective studies because this population is frequently excluded from participating in cancer trials. Evidence-based treatments for smoking-cessation with demonstrated efficacy in the general population must be routinely incorporated into the care of HIV-positive smokers.
authors.affiliation: Division of Internal Medicine, Providence Sacred Heart Medical Center, Spokane, WA 98111, USA.
authors.forename: Deepthi
authors.initials: D
authors.lastname: Mani
authors.forename: Missak
authors.initials: M
authors.lastname: Haigentz
authors.forename: David M
authors.initials: DM
authors.lastname: Aboulafia
mesh_terms: D006678:HIV / Q000472:pathogenicity*; D015658:HIV Infections / Q000150:complications* / Q000821:virology; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology*; D012307:Risk Factors